Recent News From QuaDPharma

Kinex Completes Acquisition of QuaDPharma

NEW YORK, Sept. 9, 2014 /PRNewswire/ — Kinex Pharmaceuticals Inc. today announced that it has completed the acquisition of QuaDPharma, LLC., a Western New York based privately-held company specializing in pharmaceutical manufacturing, analytical and support services to the pharmaceutical and biotech industries. Financial terms of the transaction were not disclosed. “Over the past two years,…

QuaDPharma and Empire Genomics Join Forces for Cancer Research Fundraiser

Buffalo, NY, October 31, 2013 –(PR.com)– The President and CEOs of Empire Genomics, LLC, a global molecular diagnostics company in the field of oncology, and QuaDPharma, a rapidly growing small-to-medium scale commercial contract manufacturer, will consort to host a Halloween happy hour (5-8pm) to raise funds on October 30, 2013 for bile duct cancer research…

A Life Sciences Phoenix: QuaDPharma Rises, Led By Experts from Departed WNY Firm

With help from UB, former employees of Contract Pharmaceuticals Limited have launched QuaDPharma, a Clarence-based pharmaceuticals manufacturer BUFFALO, N.Y. — Stephen Panaro, a chemist from Western New York, was working for Contract Pharmaceuticals Limited (CPL) in 2010 when the Canadian company announced plans to shut down Buffalo-based operations. Panaro declined the opportunity to move across…

Contract drug maker arises from CPL plant closing

Faced with the option of moving to Ontario to continue working at the pharmaceutical lab that was leaving Buffalo, three employees decided to stay and start their own company   When Contract Pharmaceuticals Ltd. announced plans in May 2010 to shut down its plant on the West Side and move this work to Ontario, CPL…

Selling Buffalo Bio to the world

It’s not unusual for a team of Buffalo-based institutions and companies to attend the world’s biggest biotech conference, the BIO International Convention, which is in Chicago and runs from April 22 to 25. But things are markedly different this year because they’ll be waving their own banner, “Buffalo Niagara BIO,” after years of participating in…

Life Sciences Partnering Event

Life Sciences Partnering Event  Click here to register Tour, Lecture, and Networking at QuaDPharma, llc. Brought to you by QuaDPharma and UB’s NYS Center of Excellence in Bioinformatics & Life Sciences Thursday, April 11 4 pm – 6 pm Get a look inside one of Western New York’s fastest-growing pharmaceutical manufacturers! This event will feature a…

$1 Million Invested Into QuaDPharma, LLC by Rand Capital and Advantage Capital Partners

BUFFALO, NY–(Marketwire – Nov 20, 2012) – QuaDPharma, LLC (Clarence, NY) (www.qdpharma.com) has completed a $1 million financing investment from Rand Capital SBIC, Inc. (Buffalo, NY) (www.randcapital.com) ( NASDAQ : RAND ) and Advantage Capital Partners (Glens Falls, NY) (www.advantagecap.com). QuaDPharma manufactures and tests small-batch pharmaceuticals; prescription ointments, creams and tablets that researchers or drug…

New Company Rises From Remains of Shuttered Pharmaceuticals Firm

With help from UB, former employees of Contract Pharmaceuticals Limited have launched QuaDPharma, a Clarence-based pharmaceuticals manufacturer BUFFALO, N.Y. — Stephen Panaro, a chemist from Western New York, was working for Contract Pharmaceuticals Limited (CPL) in 2010 when the Canadian company announced plans to shut down Buffalo-based operations. Like many other employees, Panaro declined the…